Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 56 matching records.
56 results — page 1 of 3
- Level BClinical TrialEurope PMC
Stem cell therapy for female stress urinary incontinence: Results, limitations and lessons learned from a pilot clinical study
Clinical Trial, published in PLoS One (2026) — summary generated from the PubMed abstract.
- 2026
PLoS One1 citations - Level DLaboratory StudyPubMed
Research Trends in Stem Cell Therapy for Stress Urinary Incontinence from 2000 to 2025: A Bibliometric Analysis.
Laboratory Study, published in Curr Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Curr Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Autologous regenerative cell therapy for female stress urinary incontinence: a systematic review and meta-analysis of clinical outcomes
Meta-analysis with a reported sample of 591, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 591
Front Med (Lausanne) - Level DAnimal StudyPubMed
The Nerve-Induced Adipose Stem Cells Promote Nerve Repair in Stress Urinary Incontinence by Regulating Schwann Cell Repair Phenotype Conversion Through Activation of the Notch Pathway.
Animal Study, published in Mol Neurobiol (2025) — summary generated from the PubMed abstract.
- 2025
Mol Neurobiol3 citations - Level DNarrative ReviewEurope PMC
Progress of mesenchymal stem cells affecting extracellular matrix metabolism in the treatment of female stress urinary incontinence
Narrative Review, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther4 citations - Level ASystematic ReviewEurope PMC
Modern Conservative Management Strategies for Female Stress Urinary Incontinence: A Systematic Review
Systematic Review, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
J Clin Med4 citations - Level BClinical TrialEurope PMC
Critical Appraisal of Evidence on Platelet-Rich Plasma and Stem Cell Therapy for Stress Urinary Incontinence: A Narrative Review
Clinical Trial, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level DAnimal StudyPubMed
Adipose-derived stem cell exosomes for stress urinary incontinence: a novel in vivo therapeutic approach.
Animal Study on Systemic / IV, published in Int Urol Nephrol (2025) — summary generated from the PubMed abstract.
- 2025
Int Urol Nephrol1 citations - Level DAnimal StudyPubMed
Myogenic induced adipose-derived stem cells sheets combined with electrospun scaffolds of silk fibroin and poly(lactide-co-glycolide) for stress urinary incontinence treatment.
Animal Study, published in J Mol Histol (2025) — summary generated from the PubMed abstract.
- 2025
J Mol Histol - Level DAnimal StudyPubMed
Injectable therapeutic system incorporating neurogenesis-programmed stem cells concomitantly promoting muscle regeneration treats stress urinary incontinence.
Animal Study, published in Nat Commun (2025) — summary generated from the PubMed abstract.
- 2025
Nat Commun - Level DNarrative ReviewEurope PMC
Stem cell-based regeneration therapies in stress urinary incontinence: Mechanisms, innovation, and challenges
Narrative Review, published in Cell Transplant (2025) — summary generated from the PubMed abstract.
- 2025
Cell Transplant1 citations - Level ASystematic ReviewEurope PMC
Cellular regenerative therapy in stress urinary incontinence: new frontiers?-a narrative review
Systematic Review, published in Transl Androl Urol (2024) — summary generated from the PubMed abstract.
- 2024
Transl Androl Urol5 citations - Level CProspective StudyPubMed
Stem Cell Application for Stress Urinary Incontinence: From Bench to Bedside.
Prospective Study, published in Curr Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Curr Stem Cell Res Ther3 citations - Level AMeta-analysisPubMed
Regenerative Medicine-Based Treatment of Stress Urinary Incontinence with Mesenchymal Stem Cells: A Systematic Review and Meta-analysis.
Meta-analysis with a reported sample of 123, published in Curr Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
- n = 123
Curr Stem Cell Res Ther - Level BClinical TrialEurope PMC
Mesenchymal stem cell-based therapy for female stress urinary incontinence
Clinical Trial, published in Front Cell Dev Biol (2023) — summary generated from the PubMed abstract.
- 2023
Front Cell Dev Biol6 citations - Level BClinical TrialEurope PMC
Treating and Managing Urinary Incontinence: Evolving and Potential Multicomponent Medical and Lifestyle Interventions
Clinical Trial on Cardiovascular Disease, published in Res Rep Urol (2023) — summary generated from the PubMed abstract.
- 2023
Res Rep Urol9 citations - Level DAnimal StudyPubMed
Periurethral and Intravenous Injections of Adipose-Derived Stem Cells to Promote Local Tissue Recovery in a Rat Model of Stress Urinary Incontinence.
Animal Study on Systemic / IV, published in Urology (2022) — summary generated from the PubMed abstract.
- 2022
Urology6 citations - Level DNarrative ReviewEurope PMC
Current status of stem cell treatments and innovative approaches for stress urinary incontinence
Narrative Review, published in Front Med (Lausanne) (2022) — summary generated from the PubMed abstract.
- 2022
Front Med (Lausanne)5 citations - Level DNarrative ReviewPubMed
Stem-cell therapy in stress urinary incontinence: A review.
Narrative Review, published in Tzu Chi Med J (2022) — summary generated from the PubMed abstract.
- 2022
Tzu Chi Med J7 citations - Level DAnimal StudyEurope PMC
Bone marrow stem cells secretome accelerates simulated birth trauma-induced stress urinary incontinence recovery in rats
Animal Study, published in Aging (Albany NY) (2021) — summary generated from the PubMed abstract.
- 2021
Aging (Albany NY)11 citations - Level DAnimal StudyPubMed
An In Vitro Study on Extracellular Vesicles From Adipose-Derived Mesenchymal Stem Cells in Protecting Stress Urinary Incontinence Through MicroRNA-93/F3 Axis.
Animal Study on Hip, published in Front Endocrinol (Lausanne) (2021) — summary generated from the PubMed abstract.
- 2021
Front Endocrinol (Lausanne)12 citations - Level DAnimal StudyPubMed
Magnetic targeting of super-paramagnetic iron oxide nanoparticle labeled myogenic-induced adipose-derived stem cells in a rat model of stress urinary incontinence.
Animal Study, published in Nanomedicine (2020) — summary generated from the PubMed abstract.
- 2020
Nanomedicine10 citations - Level BClinical TrialPubMed
Two phase I/II clinical trials for the treatment of urinary incontinence with autologous mesenchymal stem cells.
Clinical Trial with a reported sample of 9, published in Stem Cells Transl Med (2020) — summary generated from the PubMed abstract.
- 2020
- n = 9
Stem Cells Transl Med30 citations - Level BClinical TrialPubMed
Stem cell applications in regenerative medicine for stress urinary incontinence: A review of effectiveness based on clinical trials.
Clinical Trial, published in Arab J Urol (2020) — summary generated from the PubMed abstract.
- 2020
Arab J Urol20 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406